Stocks-01177.HK-Sino Biopharmaceutical Ltd

01177.HK Sino Biopharmaceutical Ltd

0 0 (0%)
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Sino Biopharmaceutical Ltd's revenues increased by 3.38% and amounted to 33.47B. Net income decreased by 70.95% to 5.82B. Net assets decreased by 7.53% to 43.44B and EPS decreased from 0.88 to 0.14.
01177.HK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
78.89%
Net Profit Margin
21.58%
Operating Margin
21.40%
Return On Investment
17.28%